How should we measure medication adherence in clinical trials and practice?

Therapeutics and Clinical Risk Management

Volumn 3, Issue 4, 2007, Pages 685-690

  Lee, Jeannie K ^a   Grace, Karen A ^a   Foster, Terri G ^a   Crawley, Monica J ^a   Erowele, Goldina I ^a   Sun, Hazel J ^a   Turner, Phuong T ^a   Sullenberger, Lance E ^a   Taylor, Allen J ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

Adherence; Hyperlipidemia; Niacin; Pharmacist; Pill count; Simvastatin

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; PLACEBO; SIMVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITAL PHARMACY; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POLYPHARMACY; RANDOMIZED CONTROLLED TRIAL; RECALL; SELF REPORT; UNITED STATES;

EID: 34848862734     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Avorn J, Monette J, Lacour A, et al. 1998. Persistence of use of lipid-lowering medications: a cross-national study. JAMA, 279:1458-62.
2. Benner JS, Glynn RJ, et al. 2002. Long-term persistence in use of statin therapy in elderly patients. JAMA, 288:455-61.
3. Botelho RJ, Dudrak R. 1992. Home assessment of adherence to long-term medication in the elderly. J Fam Pract, 35:61-5.
4. Choo PW, Rand CS, Inui TS, et al. 1999. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care, 37:846-57.
5. Christensen DB, Williams B, Goldberg HI, et al. 1997. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care, 35:1164-70.
6. Craig HM. 1985. Accuracy of indirect measures of medication compliance in hypertension. Res Nurs Health, 8:61-6.
7. Cramer JA, Mattson RH, Prevey ML, et al. 1989. How often is medication taken as prescribed? A novel assessment technique. JAMA, 261:3273-7.
8. DiMatteo MR, Giordani PJ, Lepper HS, et al. 2002. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care, 40:794-811.
9. Evans L, Spelman M. 1983. The problem of non-compliance with drug therapy. Drugs, 25:63-76.
10. Farley J, Hines S, Musk A, et al. 2003. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping. J Acquir Immune Defic Syndr, 33:211-18.
11. Farmer KC. 1999. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther, 21:1074-90.
12. Fletcher SW, Pappius EM, Harper SJ. 1979. Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin. Arch Intern Med, 139:635-8.
13. Garber MC, Nau DP, Erickson SR, et al. 2004. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care, 42:649-52.
14. Gordis L. 1984. General concepts for use of markers in clinical trials. Control Clin Trials, 5:481-7.
15. Grymonpre RE, Didur CD, Montgomery PR, et al. 1998. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother, 32:749-54.
16. Hamilton GA. 2003. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs, 2:219-28.
17. Haynes RB, Taylor DW, Sackett DL, et al. 1980. Can simple clinical measurements detect patient noncompliance? Hypertension, 2:757-64.
18. Inui TS, Carter WB, Pecoraro RE. 1981. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care, 19:1061-4.
19. Krueger KP, Felkey BG, Berger BA. 2003. Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. J Am Pharm Assoc (Wash DC), 43:668-78.
20. Liu H, Golin CE, Miller LG, et al. 2001. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med, 134:968-77.
21. Mattson ME, Friedman LM. 1984. Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood Institute. Control Clin Trials, 5:488-96.
22. Norell SE. 1984. Methods in assessing drug compliance. Acta Med Scand Suppl, 683:35-40.
23. Rudd P, Byyny RL, Zachary V, et al. 1988. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens, 1:309-12.
24. Schwed A, Fallab CL, Burnier M, et al. 1999. Electronic monitoring of compliance to lipid-lowering therapy in clinical practice. J Clin Pharmacol, 39:402-9.
25. Shalansky SJ, Levy AR, Ignaszewski AP. 2004. Self-reported Morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother, 38:1363-8.
26. Stewart M. 1987. The validity of an interview to assess a patient's drug taking. Am J Prev Med, 3:95-100.
27. Taylor AJ, Sullenberger LE, Lee HJ, et al. 2004. Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation, 110:3512-17.
28. Wright EC. 10-9-1993. Non-compliance - or how many aunts has Matilda? Lancet, 342:909-13.